Connect with us

Business

HUL, Nestle India, Britannia, Godrej Consumer Products, Marico, Dabur, Emami, Jyothy Labs et al: What’s weighing on the FMCG sector and is demand recovery in sight?

HUL, Nestle India, Britannia, Godrej Consumer Products, Marico, Dabur, Emami, Jyothy Labs et al: What’s weighing on the FMCG sector and is demand recovery in sight?

HUL, at 48.8 times its FY26 earnings, despite its market leadership and a discount to its five-year average, might see further deterioration with cut in margin guidance by 100 bps to 22-23 per cent for FY26. Its average volume growth from FY20 stands at 3 per cent, half that of the 7 per cent growth recorded during FY11-19. Dabur, with challenges in pushing sales through general trade might also see a difficult FY26, and trading at around 42 times its FY26 earnings, margin to safety seems minimal.Emami and Jyothy Labs are relatively cheaper, trading at 29 times and 31.8 times their FY26 earnings respectively. Per our recent recommendations, investors can consider accumulating in these counters.Consequently, Jyothy Labs and GCPL saw their EBITDA margin improve 10 bps and 40 bps year on year during 9M FY25. Emami, with improved offtake in its high-margin antiseptic cream and gels, saw its EBITDA and PAT margins expand 50 bps and 110 bps during 9M FY25.

Consumption blues

Softening raw material prices, particularly copra and palm oil, should help improve profitability going ahead. Also, price hike measures still underway, continuing until Q1 FY26, hints at price growth for FY26. But sustained increase in advertising and promotion expenses, to drive volume growth, will continue, limiting the expansion in profit margins. The focus continues to be on volume-driven growth and demand environment is expected to improve starting from Q2 FY26.In macro terms, the urban-rural gap in monthly per capita consumption expenditure is down to 70 per cent in 2023-24 from 84 per cent in 2011-12, signalling steady rural consumption growth. For the urban markets, a rise in disposable income, thanks to tax cuts and panel for the eighth pay commission (expected to come into effect from H2 FY26) to be appointed in the next two-three months, alongside a softening inflation is theoretically a positive set-up.However, post this underperformance, and amid global trade-war driven uncertainties, views now are again emerging in favour of FMCG stocks. But has there been a fair reset in the valuation? What’s weighing on the sector, how are companies responding and what does it all mean for long-term investors? Here is a lowdown.After many seasons of erratic monsoon post-Covid, 9M FY25 saw green shoots with better agricultural output. With the advance estimates of wheat production signalling a strong harvest and the current market prices at a premium to the minimum support price, the recovery in the rural markets seems set to continue into FY26. HUL, on the other hand, in a bid to strengthen general trade, has initiated a direct-to-kirana distribution strategy in Mumbai aimed at faster and reliable deliveries helping retailers avoid large inventory holdings.

Distribution conundrum

There is an inevitable structural shift taking place in the distribution channels and the go-to-market strategies. So, slowdown apart, changing dynamics, including D2C players gaining market share, also need to be factored while considering investments in the sector.An alternate line of thought gaining ground is that while a slowdown is observed in the growth trajectory of the listed giants, it is not entirely a result of cyclical economic slowdown and inflation in recent years. Corroboration comes from digital-first direct-to-consumer (D2C) brands, with the right formulations, continuing to grow exponentially (albeit on a low base), despite being skewed towards the urban premium. Food & BeverageWhile general trade still contributes more than half of the sector’s revenue currently, modern trade channels (including online channels) are leading the growth with healthy double-digit, year-on-year gains.Almost the entire FMCG pack forecasted a double-digit volume growth for FY25, at least from H2 FY25, with a gradual recovery in rural, while urban continues its growth trajectory. But what actually played out has been starkly different. While rural markets, which were a drag post Covid, recovered from Q4 FY24, urban markets which carried the mantle until FY24 are underperforming now.There were times when players in the industry could flex their muscles stating their huge network of distributors and kirana store retailers. HUL’s EBITDA margins were down 21 bps for FY25, while that of Marico and Dabur also dropped 70 bps and 74 bps during 9M FY25, owing to inflation in prices of palm oil, copra and fruit concentrates respectively, their key raw materials. But now some of the above factors have taken a hit. Recent years have shown that volume and earnings growth may not be consistent, and global liquidity has significantly tightened. Zero or ultra-low interest rates in developed markets meant that an FMCG stock priced at 75 times its earnings could even be attractive for a foreign investor. This is not the case anymore, with risk-free government bonds in developed markets giving attractive yields relative to high-PE FMCG stocks. So the levers for premium valuation are waning. Home & Personal CareThe recent financial performance of players, part of the FMCG index and also under our coverage, validate the evolving demand trends and shifts in margin dynamics across the sector.Home and Personal care segment continued to be the largest and fastest growing segment for HUL and Dabur.

Momentum check

But disruption has come via quick commerce (q-commerce). Though e-commerce was already in the fray, the real disruption was brought about by q-commerce, being the real alternative to the kirana stores, meeting your last-minute needs.Improved product mix helped Emami, Jyothy Labs and Godrej Consumer Products (GCPL) with their profit margins. The growth and increased penetration in high-margin liquid detergents also helped Jyothy Labs and GCPL with their profitability.To address some of the challenges here, the industry giants have warmed up to acquisitions. With healthy cash generation every year, the M&A playbook has always been integral to the incumbents. Acquiring emerging D2C brands, apart from adding to the product portfolio, has also helped expand their digital presence.Q-commerce has diluted the significance of a distribution network. Minimal investments in distribution networks meant that the focus could be channelled towards new product development and promotions. A rising quality-consciousness among consumers further levelled the field and D2C brands, with the right formulation and a focus on ingredient composition, have managed to score big. Earning brand loyalty, consequently, is more difficult now than it ever has been. This is where the sector giants are facing competition from emerging players. But the last five years tell a totally different story with Nifty FMCG index returning just 95 per cent, while Nifty 50 zoomed 159 per cent. Industry leaders like HUL and Nestle India even underperformed the sectoral index, returning a meagre 0.5 per cent and 34.5 per cent during the same period.The scale-up pace will be a key monitorable here.At the start of 2010, the Nifty FMCG index was valued at 30 times its earnings. The decade that followed (2010-19) saw earnings grow at a 13.6 per cent CAGR, while the index grew at a significantly higher CAGR of 17.1 per cent, stretching the valuation to 40 times its earnings, as at the end of 2019. While a burgeoning middle-income group drove business and earnings growth, the valuation re-rating was driven by low global interest rates and liquidity gush. Besides, investor confidence in consistency of earnings growth with most companies in the sector regarded as quality stocks, backed by a strong track record of execution and sound corporate governance added fuel. Also, the capex cycle taking a hit due to the bank clean-up during the decade meant that consumer non-discretionary plays were relatively better bets. However, urban markets are seeing premiumisation as a key trend with mass-market products, which drive the bulk of FMCG business, underperforming. And interestingly, many companies saw small packs flying off the shelves faster in Q3 FY25, which could be a sign of distress.

Outlook

Published on April 26, 2025 The Nifty FMCG index has corrected from a peak PE of 52.8 times in January 2024 to 44.3 times now. But it is still at a premium to its five-year average of 42.6 times. The pre-Covid five-year average PE is at a much lower 40.2 times, signalling that the correction might be underdone. However, these acquisitions were, more often than not, worked out at steep valuations and do not materially add to the acquirers’ topline immediately. For example, HUL’s acquisition of The Minimalist was valued at an expensive 8.5 times its FY24 revenue of ₹347 crore. But it only adds around 0.6 per cent to HUL’s FY25 revenue.

Valuation

The industry will continue to grow, but the pace at which it comes is the million-dollar-question. For the near term, changing dynamics in the distribution channels might have an impact, but in the long term, premiumisation is expected to continue being the driving factor with a focus on the product portfolio. Under-penetrated categories such as body wash liquids, functional nutritional drinks, household insecticides, oral care and hair care products could drive faster growth for Emami, Jyothy Labs, GCPL and Marico.High valuation multiples always work against share appreciation unless growth is consistent. All hinges on volume growth recovery for the industry. And at this juncture, valuation is the most critical factor for investors to find investment opportunities in this sector. Hence, tempered expectations and selective stock-picking should be the way to go.

HUL, looking to expand its offerings under the beauty and wellbeing (B&WB) segment, bought out The Minimalist in Q3 FY25. Emami, meanwhile, acquired The Man Company and Brillare Sciences, operating in the same B&WB segment. Marico, too, acquired four D2C companies – Beardo, True Elements, Just Herbs and Plix.In the earlier structure, emerging brands were stonewalled by the distribution network, but now they can compete better. And the D2C/emerging brands have turned out to be the quiet, industrious ants to the elephant-esque legacy players.While globally, FMCG/ consumer non-discretionary sectors are viewed as defensive plays, in India, for over a decade, they also served as aggressive growth bets. Why not, when GDP was growing consistently in mid- to high-single digits pulling up millions of people out of poverty and pushing them into the consumption class! On top of this, a rising affluent middle-class drove increased demand. The theme played out so well between 2010 and 2019 with Nifty FMCG index delivering 263 per cent, significantly outperforming Nifty 50 which delivered 128 per cent. HUL and Nestle India were bumper hits during this period, returning 515 per cent and 288 per cent respectively. Nestle India continues to be the most expensive, trading at 68.7 times. Marico, trading at 50.6 times its FY26 earnings, is still at a 14 per cent premium to its five-year average, leaving little room to err. Similarly, Britannia is trading at an 11 per cent premium to its five-year average and GCPL at a premium of 19 per cent. With the urban distribution channels disrupted by q-commerce, the companies have started consolidating their urban outreach, focusing on ‘high-potential outlets’, while continuing to expand their rural outreach. Companies are now even tailoring SKUs by channel to spur growth.Both Britannia and Nestle India undertook price hikes to protect their margins on account of sustained inflation in input costs. But having been late to pass on the rising input prices, despite the volume growth of around 6-8 per cent year on year during 9M FY25, Britannia’s revenue grew just 4.6 per cent. Though marginally better than FY24’s 3.5 per cent and FY20’s 4.3 per cent, it is the slowest since FY03. EBITDA margin was down 100 basis points (bps). Nestle India, similarly, found its EBITDA margin down 59 bps, while revenue grew just 3 per cent (its lowest since FY16), resulting in EBITDA being flat.

Published

on

HUL, Nestle India, Britannia, Godrej Consumer Products, Marico, Dabur, Emami, Jyothy Labs et al: What’s weighing on the FMCG sector and is demand recovery in sight?

HUL, Nestle India, Britannia, Godrej Consumer Products, Marico, Dabur, Emami, Jyothy Labs et al: What’s weighing on the FMCG sector and is demand recovery in sight?

There were times when players in the industry could flex their muscles stating their huge network of distributors and kirana store retailers. However, these acquisitions were, more often than not, worked out at steep valuations and do not materially add to the acquirers’ topline immediately. For example, HUL’s acquisition of The Minimalist was valued at an expensive 8.5 times its FY24 revenue of ₹347 crore. But it only adds around 0.6 per cent to HUL’s FY25 revenue. The scale-up pace will be a key monitorable here.

Consumption blues

While general trade still contributes more than half of the sector’s revenue currently, modern trade channels (including online channels) are leading the growth with healthy double-digit, year-on-year gains.Consequently, Jyothy Labs and GCPL saw their EBITDA margin improve 10 bps and 40 bps year on year during 9M FY25. Emami, with improved offtake in its high-margin antiseptic cream and gels, saw its EBITDA and PAT margins expand 50 bps and 110 bps during 9M FY25.High valuation multiples always work against share appreciation unless growth is consistent. All hinges on volume growth recovery for the industry. And at this juncture, valuation is the most critical factor for investors to find investment opportunities in this sector. Hence, tempered expectations and selective stock-picking should be the way to go.HUL, on the other hand, in a bid to strengthen general trade, has initiated a direct-to-kirana distribution strategy in Mumbai aimed at faster and reliable deliveries helping retailers avoid large inventory holdings.Q-commerce has diluted the significance of a distribution network. Minimal investments in distribution networks meant that the focus could be channelled towards new product development and promotions. A rising quality-consciousness among consumers further levelled the field and D2C brands, with the right formulation and a focus on ingredient composition, have managed to score big. Earning brand loyalty, consequently, is more difficult now than it ever has been. This is where the sector giants are facing competition from emerging players.

Distribution conundrum

Almost the entire FMCG pack forecasted a double-digit volume growth for FY25, at least from H2 FY25, with a gradual recovery in rural, while urban continues its growth trajectory. But what actually played out has been starkly different. While rural markets, which were a drag post Covid, recovered from Q4 FY24, urban markets which carried the mantle until FY24 are underperforming now.HUL, looking to expand its offerings under the beauty and wellbeing (B&WB) segment, bought out The Minimalist in Q3 FY25. Emami, meanwhile, acquired The Man Company and Brillare Sciences, operating in the same B&WB segment. Marico, too, acquired four D2C companies – Beardo, True Elements, Just Herbs and Plix.HUL’s EBITDA margins were down 21 bps for FY25, while that of Marico and Dabur also dropped 70 bps and 74 bps during 9M FY25, owing to inflation in prices of palm oil, copra and fruit concentrates respectively, their key raw materials. Food & BeverageThe industry will continue to grow, but the pace at which it comes is the million-dollar-question. For the near term, changing dynamics in the distribution channels might have an impact, but in the long term, premiumisation is expected to continue being the driving factor with a focus on the product portfolio. Under-penetrated categories such as body wash liquids, functional nutritional drinks, household insecticides, oral care and hair care products could drive faster growth for Emami, Jyothy Labs, GCPL and Marico.The Nifty FMCG index has corrected from a peak PE of 52.8 times in January 2024 to 44.3 times now. But it is still at a premium to its five-year average of 42.6 times. The pre-Covid five-year average PE is at a much lower 40.2 times, signalling that the correction might be underdone. In macro terms, the urban-rural gap in monthly per capita consumption expenditure is down to 70 per cent in 2023-24 from 84 per cent in 2011-12, signalling steady rural consumption growth. For the urban markets, a rise in disposable income, thanks to tax cuts and panel for the eighth pay commission (expected to come into effect from H2 FY26) to be appointed in the next two-three months, alongside a softening inflation is theoretically a positive set-up.Home and Personal care segment continued to be the largest and fastest growing segment for HUL and Dabur.While globally, FMCG/ consumer non-discretionary sectors are viewed as defensive plays, in India, for over a decade, they also served as aggressive growth bets. Why not, when GDP was growing consistently in mid- to high-single digits pulling up millions of people out of poverty and pushing them into the consumption class! On top of this, a rising affluent middle-class drove increased demand. The theme played out so well between 2010 and 2019 with Nifty FMCG index delivering 263 per cent, significantly outperforming Nifty 50 which delivered 128 per cent. HUL and Nestle India were bumper hits during this period, returning 515 per cent and 288 per cent respectively. Nestle India continues to be the most expensive, trading at 68.7 times. Marico, trading at 50.6 times its FY26 earnings, is still at a 14 per cent premium to its five-year average, leaving little room to err. Similarly, Britannia is trading at an 11 per cent premium to its five-year average and GCPL at a premium of 19 per cent. After many seasons of erratic monsoon post-Covid, 9M FY25 saw green shoots with better agricultural output. With the advance estimates of wheat production signalling a strong harvest and the current market prices at a premium to the minimum support price, the recovery in the rural markets seems set to continue into FY26.

Momentum check

However, urban markets are seeing premiumisation as a key trend with mass-market products, which drive the bulk of FMCG business, underperforming. And interestingly, many companies saw small packs flying off the shelves faster in Q3 FY25, which could be a sign of distress. Both Britannia and Nestle India undertook price hikes to protect their margins on account of sustained inflation in input costs. But having been late to pass on the rising input prices, despite the volume growth of around 6-8 per cent year on year during 9M FY25, Britannia’s revenue grew just 4.6 per cent. Though marginally better than FY24’s 3.5 per cent and FY20’s 4.3 per cent, it is the slowest since FY03. EBITDA margin was down 100 basis points (bps). Nestle India, similarly, found its EBITDA margin down 59 bps, while revenue grew just 3 per cent (its lowest since FY16), resulting in EBITDA being flat. The recent financial performance of players, part of the FMCG index and also under our coverage, validate the evolving demand trends and shifts in margin dynamics across the sector.But the last five years tell a totally different story with Nifty FMCG index returning just 95 per cent, while Nifty 50 zoomed 159 per cent. Industry leaders like HUL and Nestle India even underperformed the sectoral index, returning a meagre 0.5 per cent and 34.5 per cent during the same period.At the start of 2010, the Nifty FMCG index was valued at 30 times its earnings. The decade that followed (2010-19) saw earnings grow at a 13.6 per cent CAGR, while the index grew at a significantly higher CAGR of 17.1 per cent, stretching the valuation to 40 times its earnings, as at the end of 2019. While a burgeoning middle-income group drove business and earnings growth, the valuation re-rating was driven by low global interest rates and liquidity gush. Besides, investor confidence in consistency of earnings growth with most companies in the sector regarded as quality stocks, backed by a strong track record of execution and sound corporate governance added fuel. Also, the capex cycle taking a hit due to the bank clean-up during the decade meant that consumer non-discretionary plays were relatively better bets. Improved product mix helped Emami, Jyothy Labs and Godrej Consumer Products (GCPL) with their profit margins. The growth and increased penetration in high-margin liquid detergents also helped Jyothy Labs and GCPL with their profitability.But disruption has come via quick commerce (q-commerce). Though e-commerce was already in the fray, the real disruption was brought about by q-commerce, being the real alternative to the kirana stores, meeting your last-minute needs.With the urban distribution channels disrupted by q-commerce, the companies have started consolidating their urban outreach, focusing on ‘high-potential outlets’, while continuing to expand their rural outreach. Companies are now even tailoring SKUs by channel to spur growth.

Outlook

Published on April 26, 2025 In the earlier structure, emerging brands were stonewalled by the distribution network, but now they can compete better. And the D2C/emerging brands have turned out to be the quiet, industrious ants to the elephant-esque legacy players.However, post this underperformance, and amid global trade-war driven uncertainties, views now are again emerging in favour of FMCG stocks. But has there been a fair reset in the valuation? What’s weighing on the sector, how are companies responding and what does it all mean for long-term investors? Here is a lowdown.

Valuation

Softening raw material prices, particularly copra and palm oil, should help improve profitability going ahead. Also, price hike measures still underway, continuing until Q1 FY26, hints at price growth for FY26. But sustained increase in advertising and promotion expenses, to drive volume growth, will continue, limiting the expansion in profit margins. The focus continues to be on volume-driven growth and demand environment is expected to improve starting from Q2 FY26.There is an inevitable structural shift taking place in the distribution channels and the go-to-market strategies. So, slowdown apart, changing dynamics, including D2C players gaining market share, also need to be factored while considering investments in the sector.

But now some of the above factors have taken a hit. Recent years have shown that volume and earnings growth may not be consistent, and global liquidity has significantly tightened. Zero or ultra-low interest rates in developed markets meant that an FMCG stock priced at 75 times its earnings could even be attractive for a foreign investor. This is not the case anymore, with risk-free government bonds in developed markets giving attractive yields relative to high-PE FMCG stocks. So the levers for premium valuation are waning. An alternate line of thought gaining ground is that while a slowdown is observed in the growth trajectory of the listed giants, it is not entirely a result of cyclical economic slowdown and inflation in recent years. Corroboration comes from digital-first direct-to-consumer (D2C) brands, with the right formulations, continuing to grow exponentially (albeit on a low base), despite being skewed towards the urban premium. To address some of the challenges here, the industry giants have warmed up to acquisitions. With healthy cash generation every year, the M&A playbook has always been integral to the incumbents. Acquiring emerging D2C brands, apart from adding to the product portfolio, has also helped expand their digital presence.Home & Personal CareHUL, at 48.8 times its FY26 earnings, despite its market leadership and a discount to its five-year average, might see further deterioration with cut in margin guidance by 100 bps to 22-23 per cent for FY26. Its average volume growth from FY20 stands at 3 per cent, half that of the 7 per cent growth recorded during FY11-19. Dabur, with challenges in pushing sales through general trade might also see a difficult FY26, and trading at around 42 times its FY26 earnings, margin to safety seems minimal.Emami and Jyothy Labs are relatively cheaper, trading at 29 times and 31.8 times their FY26 earnings respectively. Per our recent recommendations, investors can consider accumulating in these counters.

Business

United Spirits Q4 PAT rises 17% to ₹451 cr for Q4FY25

United Spirits Q4 PAT rises 17% to ₹451 cr for Q4FY25
Within categories, the Prestige & Above segment grew 13.2 per cent, and the NSV for the Popular segment grew 1.1 per cent, said the company.
The growth was driven by the company’s re-entry into the Andhra Pradesh market and the resilient performance of its key trademarks, according to the company.The company’s Net Sales Value (NSV) for the quarter stood at ₹2,946 crore, up 10.5 per cent YoY. It’s gross revenue exceeded last year’s ₹6,394 crore to stand at ₹6,549 crore. Published on May 20, 2025 Shares of the company closed at ₹1,557.45, up 0.022 per cent on Tuesday on the BSE.Commenting on the result, Praveen Someshwar, CEO & Managing Director, said “The challenging demand environment notwithstanding, we have delivered 13.2 per cent NSV growth for P&A in Q4FY25 and 9.9 per cent P&A growth for FY25, and a leveraged EBITDA growth that takes us to our medium-term guidance.”Diageo India (United Spirits Ltd), a subsidiary of the British liquor giant Diageo reported a 17 per cent year-on-year increase in its standalone profit after tax (PAT) to ₹451 crore for the fourth quarter of FY25, compared to Q4 of the previous fiscal. The growth was driven by the company’s re-entry into the Andhra Pradesh market and the resilient performance of its key trademarks

For the full year FY25, it reported a PAT of ₹1,158 crore, up from last fiscal’s ₹1,312 crore.

Published

on

United Spirits Q4 PAT rises 17% to ₹451 cr for Q4FY25

United Spirits Q4 PAT rises 17% to ₹451 cr for Q4FY25
The company’s Net Sales Value (NSV) for the quarter stood at ₹2,946 crore, up 10.5 per cent YoY. It’s gross revenue exceeded last year’s ₹6,394 crore to stand at ₹6,549 crore.
For the full year FY25, it reported a PAT of ₹1,158 crore, up from last fiscal’s ₹1,312 crore. Within categories, the Prestige & Above segment grew 13.2 per cent, and the NSV for the Popular segment grew 1.1 per cent, said the company.The growth was driven by the company’s re-entry into the Andhra Pradesh market and the resilient performance of its key trademarks, according to the company.Shares of the company closed at ₹1,557.45, up 0.022 per cent on Tuesday on the BSE.Commenting on the result, Praveen Someshwar, CEO & Managing Director, said “The challenging demand environment notwithstanding, we have delivered 13.2 per cent NSV growth for P&A in Q4FY25 and 9.9 per cent P&A growth for FY25, and a leveraged EBITDA growth that takes us to our medium-term guidance.”Diageo India (United Spirits Ltd), a subsidiary of the British liquor giant Diageo reported a 17 per cent year-on-year increase in its standalone profit after tax (PAT) to ₹451 crore for the fourth quarter of FY25, compared to Q4 of the previous fiscal. The growth was driven by the company’s re-entry into the Andhra Pradesh market and the resilient performance of its key trademarks

Published on May 20, 2025

Continue Reading

Business

DLF Q4 net profit rises 37% to ₹1,268 cr; FY25 profit surges 59%

DLF Q4 net profit rises 37% to ₹1,268 cr; FY25 profit surges 59%
The other big-ticket launch, DLF Privana West, witnessed a complete sellout within a few days of the soft launch, clocking approximately ₹5,600 crore of new sales bookings.
“The Dahlias, received encouraging demand and generated ₹13,744 crore in new sales bookings during the fiscal. This has resulted in the monetization of approximately 39 percent of the estimated total sales potential of this project within the first year of its launch,” the company said in a statement. The country’s largest realtor, DLF, reported a net profit of ₹1,268 crore, up 37 per cent y-o-y, for the quarter ending March 31, 2025. Revenue (consolidated) for the period stood at ₹3,348 crore.DLF’s annuity business, DLF Cyber City Developers Limited (DCCDL), stood at ₹6,448 crore; EBITDA stood at ₹4,949 crore, reflecting a y-o-y growth of 11%; consolidated profit for the year stood at ₹2,461 crore, a y-o-y growth of 46%.DLF ended FY25 with a net cash surplus of ₹5,302 crore and improved its net cash position to ₹6,848 crore. 

“The Board has recommended a dividend of ₹6 per share for shareholders’ approval. This payout would signify a year-on-year growth of 20% in the dividend compared to the previous year,” the company said in a statement.For the full year, the company’s net profit stood at ₹4,357 crore, up 59 per cent y-o-y; while revenues (consolidated) stood at Rs 8996 crore. Revenue was driven by new sales bookings of ₹21,223 crore, up 44 per cent y-o-y.Published on May 19, 2025 The company generated a net cash surplus of ₹5,302 crore during the fiscal year, and its net cash position improved to ₹6,848 crore for FY25.

Published

on

DLF Q4 net profit rises 37% to ₹1,268 cr; FY25 profit surges 59%

DLF Q4 net profit rises 37% to ₹1,268 cr; FY25 profit surges 59%
DLF ended FY25 with a net cash surplus of ₹5,302 crore and improved its net cash position to ₹6,848 crore. 

DLF’s annuity business, DLF Cyber City Developers Limited (DCCDL), stood at ₹6,448 crore; EBITDA stood at ₹4,949 crore, reflecting a y-o-y growth of 11%; consolidated profit for the year stood at ₹2,461 crore, a y-o-y growth of 46%.Published on May 19, 2025 The company generated a net cash surplus of ₹5,302 crore during the fiscal year, and its net cash position improved to ₹6,848 crore for FY25.“The Board has recommended a dividend of ₹6 per share for shareholders’ approval. This payout would signify a year-on-year growth of 20% in the dividend compared to the previous year,” the company said in a statement.For the full year, the company’s net profit stood at ₹4,357 crore, up 59 per cent y-o-y; while revenues (consolidated) stood at Rs 8996 crore. Revenue was driven by new sales bookings of ₹21,223 crore, up 44 per cent y-o-y.The other big-ticket launch, DLF Privana West, witnessed a complete sellout within a few days of the soft launch, clocking approximately ₹5,600 crore of new sales bookings.“The Dahlias, received encouraging demand and generated ₹13,744 crore in new sales bookings during the fiscal. This has resulted in the monetization of approximately 39 percent of the estimated total sales potential of this project within the first year of its launch,” the company said in a statement. The country’s largest realtor, DLF, reported a net profit of ₹1,268 crore, up 37 per cent y-o-y, for the quarter ending March 31, 2025. Revenue (consolidated) for the period stood at ₹3,348 crore.

Continue Reading

Business

Editorial. Pressure tactics

Editorial. Pressure tactics
In a move that perhaps marks a shift in the way India is approaching trade talks with the US, the External Affairs Minister S Jaishankar has firmly refuted the US’ claim, made repeatedly in recent weeks, that India has agreed to nil tariffs on US imports. Jaishankar’s statement last week tersely and firmly clarifies that trade talks are in progress, and ‘nothing is decided until everything is decided’. India has cleared the air, and it was high time that it did so. It coincides with the upcoming trade talks between the two countries this week; Commerce and Industries Minister Piyush Goyal is in the US with his team of negotiators.
There is scope to bring down tariffs in products which are zero-rated with other FTAs. A deal that brings down tariffs on India’s goods to 10 per cent is possible without much sacrifice. But Trump’s bluff and bluster must be called out, whether it is over trade or matters of national security, even as we keep our ties with US on an even keel. Published on May 18, 2025 External Affairs Minister S Jaishankar

Since April 8, when President Trump slapped his reciprocal tariffs on 57 countries with a 90-day deadline for them to take effect, his administration has gone overboard in ramping up the pressure on India. The gambit here is crudely simple — to force India to ink a deal in these 90 days, before July 8, in order to escape the 26 per cent tariffs that are expected to kick in after that. The same trick is being played out with the rest of the world as well, forcing quite a few countries to line up for talks with the US. In India’s case, Trump and his colleagues have cynically generated a lot of confusion. India has maintained a studied silence in the face of zero tariff claims. Its reticence was perhaps aimed at ensuring that the talks proceeded in good faith. But US’ actions have marred the process. Trump has proposed a ‘big beautiful Bill’ that may ‘tax’ 5 per cent of billion NRI remittance outflows. India should be circumspect in the face of pressure, without allowing the US to set the pace in the talks. A bad deal cobbled in haste is far worse than none at all. Meanwhile, India sent out another sharp message that it will look out for its interests. In a throwback to Trump 1.0, India has proposed retaliatory action on US’ tariffs on steel and aluminium. However, it needs to work out a plan with respect to other areas as well. At the outset, it should be clear that the US’ interests in India go beyond trade per se to persuading India to alter its regulatory systems with respect to GM food, e-commerce, big tech, pharma and other high tech sectors. It is also keen on access to India’s food (maize and soyabean) and dairy sector, besides selling defence equipment and oil. India has enough in its toolkit to squeeze a deal that does not hurt its interests. A levy on e-commerce monopolies, a cap on royalty payments, applying data localisation rules and compulsory licensing of patented drugs can be used to ward off an adverse outcome.

Published

on

Editorial. Pressure tactics

Editorial. Pressure tactics
Published on May 18, 2025
Since April 8, when President Trump slapped his reciprocal tariffs on 57 countries with a 90-day deadline for them to take effect, his administration has gone overboard in ramping up the pressure on India. The gambit here is crudely simple — to force India to ink a deal in these 90 days, before July 8, in order to escape the 26 per cent tariffs that are expected to kick in after that. The same trick is being played out with the rest of the world as well, forcing quite a few countries to line up for talks with the US. In India’s case, Trump and his colleagues have cynically generated a lot of confusion. India has maintained a studied silence in the face of zero tariff claims. Its reticence was perhaps aimed at ensuring that the talks proceeded in good faith. But US’ actions have marred the process. Trump has proposed a ‘big beautiful Bill’ that may ‘tax’ 5 per cent of billion NRI remittance outflows. India should be circumspect in the face of pressure, without allowing the US to set the pace in the talks. A bad deal cobbled in haste is far worse than none at all. External Affairs Minister S Jaishankar

There is scope to bring down tariffs in products which are zero-rated with other FTAs. A deal that brings down tariffs on India’s goods to 10 per cent is possible without much sacrifice. But Trump’s bluff and bluster must be called out, whether it is over trade or matters of national security, even as we keep our ties with US on an even keel. Meanwhile, India sent out another sharp message that it will look out for its interests. In a throwback to Trump 1.0, India has proposed retaliatory action on US’ tariffs on steel and aluminium. However, it needs to work out a plan with respect to other areas as well. At the outset, it should be clear that the US’ interests in India go beyond trade per se to persuading India to alter its regulatory systems with respect to GM food, e-commerce, big tech, pharma and other high tech sectors. It is also keen on access to India’s food (maize and soyabean) and dairy sector, besides selling defence equipment and oil. India has enough in its toolkit to squeeze a deal that does not hurt its interests. A levy on e-commerce monopolies, a cap on royalty payments, applying data localisation rules and compulsory licensing of patented drugs can be used to ward off an adverse outcome. In a move that perhaps marks a shift in the way India is approaching trade talks with the US, the External Affairs Minister S Jaishankar has firmly refuted the US’ claim, made repeatedly in recent weeks, that India has agreed to nil tariffs on US imports. Jaishankar’s statement last week tersely and firmly clarifies that trade talks are in progress, and ‘nothing is decided until everything is decided’. India has cleared the air, and it was high time that it did so. It coincides with the upcoming trade talks between the two countries this week; Commerce and Industries Minister Piyush Goyal is in the US with his team of negotiators.

Continue Reading

Trending